IOL Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
For the nine months, sales was INR 16,288.7 million compared to INR 16,299 million a year ago. Revenue was INR 16,514.2 million compared to INR 16,467.8 million a year ago. Net income was INR 1,068.1 million compared to INR 743.6 million a year ago. Basic earnings per share from continuing operations was INR 18.19 compared to INR 12.67 a year ago. Diluted earnings per share from continuing operations was INR 18.19 compared to INR 12.67 a year ago.